Oral misoprostol reduces vaginal bleeding following surgical evacuation for first trimester spontaneous abortion

Int J Gynaecol Obstet. 2009 Nov;107(2):117-20. doi: 10.1016/j.ijgo.2009.06.008. Epub 2009 Jul 18.

Abstract

Objective: To assess the effectiveness and tolerability of misoprostol to reduce the amount and duration of vaginal bleeding following surgical evacuation for first trimester spontaneous abortion.

Methods: A total of 160 patients who underwent surgical evacuation for first trimester spontaneous abortion between 8 and 12 weeks of pregnancy were randomized into 2 groups to receive either 200 microg of oral misoprostol immediately after evacuation followed every 6 hours for 48 hours or no misoprostol. Pain scores, duration and amount of bleeding, and endometrial thickness were assessed over 10 days.

Results: Women who received misoprostol had significantly fewer bleeding days after evacuation (4.11+/-2.69 vs 5.89+/-3.06; P<0.001), fewer patients reported vaginal bleeding lasting 10 days or more (3.8% vs 15.0%; P=0.014), and endometrial thickness 10 days after evacuation was less (6.25+/-2.38 vs 7.23+/-1.94; P=0.05). Pain scores were comparable in both groups (1.54+/-0.65 vs 1.63+/-0.83; P=0.40) after 10 days.

Conclusion: Oral misoprostol is effective in reducing the prevalence and amount of vaginal bleeding after surgical evacuation for first trimester spontaneous abortion.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Abortion, Spontaneous / drug therapy*
  • Administration, Oral
  • Adult
  • Endometrium / metabolism
  • Female
  • Follow-Up Studies
  • Humans
  • Misoprostol / administration & dosage
  • Misoprostol / adverse effects
  • Misoprostol / therapeutic use*
  • Oxytocics / administration & dosage
  • Oxytocics / adverse effects
  • Oxytocics / therapeutic use*
  • Pain / etiology
  • Pain Measurement
  • Pregnancy
  • Pregnancy Trimester, First
  • Prospective Studies
  • Treatment Outcome
  • Uterine Hemorrhage / drug therapy*
  • Uterine Hemorrhage / etiology
  • Young Adult

Substances

  • Oxytocics
  • Misoprostol